| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |